PlainRecalls
FDA Devices Critical Class I Ongoing

Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test)

Reported: March 16, 2022 Initiated: January 13, 2022 #Z-0717-2022

Product Description

Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test)

Reason for Recall

COVID-19 test kits (Antibody Rapid Test kit and Antigen Rapid Test Kit) are not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Details

Recalling Firm
Lusys Laboratories, Inc.
Units Affected
90,849 kits
Distribution
Worldwide - US Nationwide distribution in the states of CA, NC, NV, OH, TN and TX. The countries of Canada, China, and Mexico. Pending additional information for a complete Consignee Listing
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test). Recalled by Lusys Laboratories, Inc.. Units affected: 90,849 kits.
Why was this product recalled?
COVID-19 test kits (Antibody Rapid Test kit and Antigen Rapid Test Kit) are not authorized, cleared, or approved for marketing and/or distribution in the U.S.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 16, 2022. Severity: Critical. Recall number: Z-0717-2022.